Giorgio Stassi

Giorgio Stassi (born 22 June 1965, in Palermo) is an Italian scientist.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 3 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Giorgio Stassi (born 22 June 1965, in Palermo) is an Italian scientist.

Early life

He studied medicine at the University of Palermo and graduated in 1991, when he was awarded the university prize with special mention for his curriculum vitae and doctoral thesis. He became a specialist in Endocrinology in 1996.

Honors

1991 Winner of the scholarship for medical residents (art. 6, Italian Law Decree 257/91) for the School of Specialization in “Endocrinology and Metabolic Diseases”; 1997 Cover issue, Science, 275:1997; 1998 Cover issue, Circulation, 98:1998; 1998 Young Investigator Award, University of Palermo; 1999 Cover issue, Blood, 93:1999; 1999 Cover issue, Circulation Research, 85:1999; 2004 Cover issue, FASEB Journal, 18:2004; 2004 Award within the National Stem Cell Program (file 515°) for the characterization and purification of stem cells from solid tumors and the transfer of tumors generated by these cells in animal models; 2004 Award (call of 26 January 2004, FABT) for the development of advanced technologies for sensitizing tumor cells; 2009 “L’Altra Italia – Vite da Premio” Award, “Scientific Research” section; 2010 Cover issue, Gastroenterology, 138:2010; 2021 International Federation of Journalists and Travel Writers Award for “Scientific Progress in Oncology”; 2024 Ambassador of Sicilian Culture and Identity, Associazione della Cultura Teatro L. Giani; 2024 Ambassador for advances in translational medicine and resilience for future generations of researchers in Southern Italy, HEAL Italia Foundation; 2026 Career Award for research in clinical and experimental oncology, “Carlo Chianello” Foundation.

Patents

Sensitizing cells for apoptosis by selectively blocking cytokines. US2006257401 – 2006-11-16; Method for the purification and amplification of tumoral stem cells. EP1805299 – 2007-07-11; Sensitizing cells for apoptosis by selectively blocking cytokines.

EP1592449 – 2005-11-09; Antibody specific for Human IL-4 for Treatment of Cancer. WO2007107349 – 2007-09-27; Combination of kinase inhibitor for treating colorectal cancer.

Research focus

His profile builds on a solid background in immunology, endocrinology and cell biology, with pioneering contributions on apoptosis in autoimmune diseases and diabetes mellitus. Subsequently, his research has focused on the survival, treatment resistance and plasticity of cancer stem cells, helping to define their role in tumor initiation, progression, metastasis and chemo‑resistance across several solid malignancies (colon, thyroid, breast, lung, central nervous system), using in vitro and in vivo preclinical models and “tumor‑on‑chip” platforms integrating immune and stromal components.

In immunology, his focused on mechanisms of immune escape in transplantation, the biology of T lymphocytes and NK cells, advanced cellular immunotherapies (including γδ T cells, T effector cells and CAR‑like approaches), tumor stem cell‑mediated immunoregulation, and the identification of biomarkers predictive of response to immunotherapy. In parallel, he has developed regenerative medicine projects and studies on the interactions among metabolism, obesity, the adipose tumor microenvironment and cancer, spanning from tissue engineering to cell‑based therapies.

Stassi's work has allowed the acquisition of multi-omics platforms (genomics, bulk and single cell transcriptomics, epigenomics, proteomics, metagenomics) tightly integrated with clinical practice, to establish core facilities for experimental pathology and multiplex tissue imaging for spatial characterization of the microenvironment in order to build infrastructures for big data management and for the application of machine learning/AI algorithms in support of precision medicine, and to strengthen technology transfer and the creation of deep tech start ups.

References

https://www.cmol.it/

Text derived from https://en.wikipedia.org/w/index.php?oldid=1347340372 under CC BY-SA 4.0; modifications have been made.

References

1 claim could not be tied to a specific sentence and is listed in the table below instead.